Albemarle CORP Stock: price and management transactions · United States · SEC (Form 4)Follow the Albemarle CORP stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Chemicals & Materials sector, Albemarle CORP has published 244 public disclosures. Market capitalisation: €14bn. The latest transaction was filed on 23 July 2026 (Attribution). Among the most active insiders: Norris Eric. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate Albemarle CORP Buy (bullish), based on 20 analysts. Average price target: US$196.41.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,743 of 29,057 companies
FCF yld 4.3%
Earn yld -4.2%
EV/EBITDA ·
ROE 2.6%
Gross mgn 13%
Net mgn -13%
Debt/EBITDA 10.5x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 July 2026
All Executives244 Thresholds0 Prospectus0 Other0
Declarations 244 total
◆ Director · Executives · 21 Jul 2026
1,375 shares 0Common Stock SEC:0000915913-26-000097:0
● Director · Executives · 1 Jul 2026
929 shares @ US$136.08 0.0008% mcap 98.6% of flow Common Stock SEC:0001913598-26-000002:1
● Director · Executives · 1 Jul 2026
13 shares @ US$136.08 0.0000% mcap 1.4% of flow Common Stock SEC:0001913598-26-000002:3
◆ Director · Executives · 1 Jul 2026
33 shares 0Common Stock SEC:0001585657-26-000007:0
◆ Director · Executives · 1 Jul 2026
1,250 shares 0Common Stock SEC:0001235612-26-000002:0
◆ Director · Executives · 1 Jul 2026
1,250 shares 0Common Stock SEC:0002047429-26-000010:0
◆ Director · Executives · 1 Jul 2026
36 shares 0Common Stock SEC:0001235612-26-000002:1
◆ Director · Executives · 1 Jul 2026
1,250 shares 0Common Stock SEC:0001730941-26-000002:0
◆ Director · Executives · 1 Jul 2026
1,250 shares 0Common Stock SEC:0001143210-26-000003:0
◆ Director · Executives · 1 Jul 2026
36 shares 0Common Stock SEC:0001143210-26-000003:1
◆ Director · Executives · 1 Jul 2026
36 shares 0Common Stock SEC:0001730941-26-000002:1
◆ Director · Executives · 1 Jul 2026
1,250 shares 0Common Stock SEC:0001913598-26-000002:0
◆ Director · Executives · 1 Jul 2026
36 shares 0Common Stock SEC:0001913598-26-000002:2
◆ Director · Executives · 1 Jul 2026
2 shares 0Common Stock SEC:0002047429-26-000010:1
▼ Chairman & CEO · Executives · 15 May 2026
3,826 shares @ US$183.12 0.0029% mcap 11.0% of flow Common Stock SEC:0000915913-26-000080:0
▼ Chairman & CEO · Executives · 15 May 2026
11,867 shares @ US$183.87 0.0090% mcap 34.2% of flow Common Stock SEC:0000915913-26-000080:1
▼ Chairman & CEO · Executives · 15 May 2026
700 shares @ US$184.52 0.0005% mcap 2.0% of flow Common Stock SEC:0000915913-26-000080:2
◆ Director · Executives · 1 Apr 2026
25 shares 0Common Stock SEC:0000915913-26-000062:0
▼ Chairman & CEO · Executives · 10 Mar 2026
5,395 shares @ US$170.26 10.8% of flow Common Stock SEC:0001396415-26-000010:0
◆ Director · Executives · 3 Oct 2023
25 shares 0Common Stock SEC:0001585657-26-000004:0
◆ Director · Executives · 3 Jan 2024
29 shares 0Common Stock SEC:0001585657-26-000004:1
◆ Director · Executives · 2 Apr 2024
32 shares 0Common Stock SEC:0001585657-26-000004:2
◆ Director · Executives · 1 Oct 2024
46 shares 0Common Stock SEC:0001585657-26-000004:4
◆ Director · Executives · 1 Jul 2024
42 shares 0Common Stock SEC:0001585657-26-000004:3
◆ Director · Executives · 2 Jan 2026
32 shares 0Common Stock SEC:0001585657-26-000004:5
25 of 244 declarations
Load more (219 remaining) 关于 Albemarle CORP Albemarle Corp. (NYSE: ALB) 是一家总部位于美国北卡罗来纳州夏洛特的美国特种化学品公司,在美国纽约证券交易所上市。公司历史可追溯至1887年,Albemarle Corporation 于1994年成为一家上市公司。随着时间的推移,公司业务已从其历史上的工业和造纸传统演变为一个更专注于锂、溴和催化剂的特种化学品平台。([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf))
如今,Albemarle 将自己定位为全球最大的锂供应商之一和溴解决方案领域的行业领导者。其主要运营支柱是锂解决方案、溴解决方案和催化剂。锂业务包括氢氧化锂、碳酸锂、金属锂以及用于电动汽车电池、储能和更广泛工业应用的特种有机金属化合物和盐。溴产品组合涵盖阻燃剂、工业水处理、消防安全、环境修复和钻井液应用,而其催化剂业务则服务于炼油和石化客户。这种组合使公司既能受益于能源转型需求,又能服务于更传统的工业终端市场。([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf))
从地理上看,Albemarle 拥有广泛的全球业务足迹,为大约70个国家的客户提供服务。公司强调其差异化的资产基础,包括美国唯一运营的锂矿,以及智利的盐湖资产、澳大利亚的硬岩和合资资产,以及北美、南美、欧洲和亚洲的转化和研发设施。从矿山和盐湖到成品化学品的这种整合是其关键的竞争优势,支持了供应可靠性和产品质量。([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf))
从竞争角度来看,Albemarle 受益于规模、资源质量、技术专长和长期客户关系。与此同时,公司仍然高度受锂价格周期的影响,这在近期对盈利和资本配置造成了压力。最近的公司更新显示出更严谨的运营姿态:2025年期间,公司强调了成本和生产力措施,并于2026年2月宣布计划闲置其位于西澳大利亚Kemerton氢氧化锂加工厂剩余的运营生产线,以保持财务灵活性。Albemarle 的2025年全年业绩也显示出正的运营现金流和可观的自由现金流产生,2026年资本支出预计将与2025年大致持平。因此,对于投资者而言,该名称结合了对电气化的战略敞口和仍具周期性的盈利状况。([investors.albemarle.com](https://investors.albemarle.com/news-and-events/news/news-details/2026/Albemarle-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx?utm_source=openai))